Alkermes plc
ALKS
|
$23.86
0.42%
0.42%
2.4M
|
Health Technology
(0.0% 1d) (-11.6% 1m) (-18.8% 1y) (0.4% 2d) (-1.1% 3d) (-0.7% 7d) (34.24% volume)
Earnings Calendar: 2024-02-15
Market Cap: $ 4,036,734,606
http://www.alkermes.com
Sec Filling | Patents | 2235 employees
Alkermes Plc is a biopharmaceutical company, which engages in the development, research, and commercialization of medicines that are designed to address unmet medical needs of patients in major therapeutic areas. Its products include Aristada, which is used for the treatment of schizophrenia in adults; and Vivitrol, which is an injectable medication for the treatment of alcohol dependence and for the prevention of relapse to opioid dependence, following opioid detoxification. The company was founded on May 4, 2011 and is headquartered in Dublin, Ireland.
schizophrenia opioid neurodegenerative urea treatment injection
Drugs
ARISTADA (aripiprazole lauroxil)ARISTADA INITIO (aripiprazole lauroxil)
VIVITROL (naltrexone)
add to watch list Paper trade email alert is off
Press-releases
Alkermes to Report First Quarter Financial Results on May 1, 2024
Published: 2024-04-17 (Crawled : 20:00) - prnewswire.com
ALKS | $23.86 0.42% 0.42% 2.4M
|
Health Technology
|
| O: -1.08%
H: 1.17%
C: -0.42%
first report financial results
Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia
Published: 2024-04-09 (Crawled : 13:00) - biospace.com/
ALKS | $23.86 0.42% 0.42% 2.4M
|
Health Technology
|
| O: 4.48%
H: 0.82%
C: -2.05%
narcolepsy positive topline results study
Alkermes Presents Analyses From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan) at 2024 Congress of the Schizophrenia International Research Society
Published: 2024-04-08 (Crawled : 15:00) - biospace.com/
ALKS | $23.86 0.42% 0.42% 2.4M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
lybalvi congress international research schizophrenia study
A2 Bio Appoints James Robinson as New Chief Executive Officer and Member of the Board of Directors
Published: 2024-03-25 (Crawled : 13:30) - biospace.com/
URGN | $13.78 -3.37% -3.48% 390K
|
Health Technology
|
| O: 2.73%
H: 12.6%
C: 2.9%
ALKS | $23.86 0.42% 0.42% 2.4M
|
Health Technology
|
| O: 0.29%
H: 0.71%
C: -0.22%
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
Published: 2024-03-07 (Crawled : 12:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.04%
H: 0.44%
C: -1.51%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -2.08%
H: 0.13%
C: -0.57%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.36%
H: 0.34%
C: -0.54%
XFOR | $1.255 4.58% 4.38% 3M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: -4.98%
EYPT | $17.665 0.94% 0.93% 1.5M
|
Health Technology
|
| O: 2.56%
H: 1.37%
C: -4.13%
AQST | $4.11 -8.67% -9.49% 2.3M
|
Health Technology
|
| O: 1.79%
H: 12.3%
C: 10.94%
ALKS | $23.86 0.42% 0.42% 2.4M
|
Health Technology
|
| O: 1.11%
H: 0.96%
C: 0.65%
Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2023 and Provides Financial Expectations for 2024
Published: 2024-02-15 (Crawled : 13:00) - biospace.com/
MURA | $3.55 -0.56% -0.56% 240K
|
|
| O: 2.78%
H: 8.11%
C: 3.53%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.19%
H: 1.6%
C: 1.24%
ALKS | $23.86 0.42% 0.42% 2.4M
|
Health Technology
|
| O: 2.72%
H: 13.77%
C: 13.25%
year financial results
Seeking Alpha Service: Expert Opinions and Smart Investing Converge
Published: 2024-02-13 (Crawled : 19:00) - prnewswire.com
SLVM 4 | $58.46 2.8% 0.0% 380K
|
Manufacturing
|
| O: 0.26%
H: 0.55%
C: -0.31%
ZYME | $8.85 2.08% 2.03% 550K
|
Health Technology
|
| O: 1.06%
H: 1.23%
C: 0.09%
YALA | $4.52 -1.53% -1.55% 390K
|
Technology Services
|
| O: 0.42%
H: 2.33%
C: 1.9%
VST | $65.66 -0.33% 0.0% 7.5M
|
Utilities
|
| O: 0.75%
H: 1.06%
C: -0.58%
TNK | $56.53 1.82% 0.0% 330K
|
Transportation
|
| O: 0.84%
H: 0.07%
C: -1.45%
SYF | $41.57 1.89% 0.0% 4.5M
|
Finance
|
| O: 1.27%
H: 0.55%
C: 0.49%
STNG | $69.53 1.56% 0.0% 720K
|
Transportation
|
| O: 0.04%
H: 2.1%
C: -1.79%
RGA | $186.52 2.21% 0.0% 520K
|
Finance
|
| O: 0.26%
H: 1.74%
C: 1.58%
PGTI | $41.99 -0.0% 2.2M
|
Producer Manufacturing
|
| O: 0.1%
H: 0.12%
C: -0.07%
PARR | $31.76 2.22% 0.0% 730K
|
Energy Minerals
|
| O: 0.96%
H: 0.63%
C: 0.2%
PAM | $43.08 2.84% 0.0% 230K
|
Utilities
|
| O: 0.3%
H: 2.14%
C: 1.06%
PAGS | $11.48 -0.61% 0.0% 9M
|
Commercial Services
|
| O: 1.63%
H: 1.6%
C: 1.15%
EPRT A | $25.48 1.27% 2.16% 1.3M
|
Finance
|
| O: 0.17%
H: 0.37%
C: -0.21%
ENIC | $2.92 0.31% 170K
|
Utilities
|
| O: 1.85%
H: 2.55%
C: 1.82%
DESP | $11.64 2.83% 0.17% 670K
|
Consumer Services
|
| O: 0.99%
H: 2.2%
C: 1.59%
DHI | $142.19 -2.53% 0.06% 3.4M
|
Consumer Durables
|
| O: 1.29%
H: 1.46%
C: 0.89%
CNC | $75.15 1.9% 0.0% 2.7M
|
Health Services
|
| O: 0.26%
H: 0.83%
C: 0.77%
ASC | $15.88 1.86% 0.0% 470K
|
Transportation
|
| O: 0.67%
H: 0.41%
C: -1.57%
STNE | $15.3 0.26% 0.26% 7.2M
|
Technology Services
|
| O: 1.65%
H: 1.85%
C: 1.27%
SPOK | $15.0 0.74% 0.73% 98K
|
Communications
|
| O: 0.93%
H: 0.49%
C: -0.06%
RCMT | $19.14 0.21% 0.16% 52K
|
Industrial Services
|
| O: 0.7%
H: 1.71%
C: 0.63%
PGTI | $41.99 -0.0% 2.2M
|
Producer Manufacturing
|
| O: 0.1%
H: 0.12%
C: -0.07%
MGNX | $15.62 -2.8% -2.88% 1M
|
Health Technology
|
| O: -4.21%
H: 6.5%
C: 3.07%
LMB 4 | $39.35 -1.67% -1.7% 300K
|
Miscellaneous
|
| O: 1.85%
H: 4.24%
C: 4.24%
LI | $26.365 -9.65% -10.68% 12M
|
Producer Manufacturing
|
| O: 2.58%
H: 0.2%
C: -1.53%
ITRN | $24.99 -0.12% -0.12% 21K
|
Electronic Technology
|
| O: 1.74%
H: 2.41%
C: 2.33%
FCNCA | $1568.1 1.04% 1.03% 65K
|
Finance
|
| O: 0.87%
H: 1.12%
C: 0.01%
FITB | $36.225 5.86% 5.53% 14M
|
Finance
|
| O: 1.28%
H: 1.04%
C: 0.81%
ESEA | $33.45 1.98% 1.94% 20K
|
Transportation
|
| O: 1.12%
H: 1.28%
C: -3.77%
CCAP | $17.165 0.5% 0.5% 78K
|
Finance
|
| O: 0.37%
H: 0.06%
C: -0.12%
BWAY | $4.835 0.94% 0.93% 41K
|
Health Technology
|
| O: 2.18%
H: 6.4%
C: -0.3%
BELFB | $56.62 1.05% 1.04% 73K
|
Electronic Technology
|
| O: 1.22%
H: 5.5%
C: 4.52%
BELFA | $69.18 -0.04% -0.04% 7.3K
|
Electronic Technology
|
| O: 1.03%
H: 4.49%
C: 4.04%
ARCT 4 | $25.995 -1.23% -1.25% 630K
|
Health Technology
|
| O: 2.14%
H: 0.58%
C: -2.88%
ALKS | $23.86 0.42% 0.42% 2.4M
|
Health Technology
|
| O: 0.99%
H: 1.93%
C: 1.78%
SILV | $7.9 4.36% 0.0% 2.1M
|
Non-Energy Minerals
|
| O: 0.59%
H: 1.56%
C: 0.2%
smart
Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 15, 2024
Published: 2024-02-08 (Crawled : 21:00) - prnewswire.com
ALKS | $23.86 0.42% 0.42% 2.4M
|
Health Technology
|
| O: 0.56%
H: 1.67%
C: 1.49%
report financial results
Alkermes to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-03 (Crawled : 21:00) - prnewswire.com
ALKS | $23.86 0.42% 0.42% 2.4M
|
Health Technology
|
| O: 1.12%
H: 0.03%
C: -1.24%
conference
Alkermes plc Announces Agreement to Sell Athlone, Ireland Facility to Novo Nordisk
Published: 2023-12-14 (Crawled : 11:00) - prnewswire.com
MURA | $3.55 -0.56% -0.56% 240K
|
|
| O: 0.26%
H: 0.78%
C: -5.99%
ALKS | $23.86 0.42% 0.42% 2.4M
|
Health Technology
|
| O: 0.66%
H: 1.18%
C: -2.36%
ireland agreement
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M
|
n/a
|
23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M
|
Finance
|
22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K
|
Health Technology
|
22:30
BCDA P 2750 | $0.377 -1.4% 97K
|
Health Technology
|
22:00
RMCF | $3.67 3.38% 3.27% 11K
|
Consumer Non-Durables
|
20:10